Chronic hepatitis B: What should be the goal for new therapies?
- 4 February 2013
- journal article
- editorial
- Published by Elsevier BV in Antiviral Research
- Vol. 98 (1), 27-34
- https://doi.org/10.1016/j.antiviral.2013.01.006
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Identification of Disubstituted Sulfonamide Compounds as Specific Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA FormationAntimicrobial Agents and Chemotherapy, 2012
- Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic reviewJournal of Hepatology, 2010
- Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucksJournal of Hepatology, 2010
- The mannose receptor acts as hepatitis B virus surface antigen receptor mediating interaction with intrahepatic dendritic cellsVirology, 2009
- The Challenge of Finding a Cure for HIV InfectionScience, 2009
- Hepatitis B Virus InfectionThe New England Journal of Medicine, 2008
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 updateHepatology International, 2008
- Molecular Virology of Hepatitis B Virus for CliniciansClinics in Liver Disease, 2007
- The role of cells refractory to productive infection in acute hepatitis B viral dynamicsProceedings of the National Academy of Sciences of the United States of America, 2007
- Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapyGastroenterology, 2004